A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC

This publication has 21 references indexed in Scilit:

• APC of Breast Diseases: Breast Cancer - Epidemiology, risk factors, and Genetics
  BMJ, 1994
• Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
  JNCI Journal of the National Cancer Institute, 1991
• Cancer in the European community and its member states
  European Journal of Cancer and Clinical Oncology, 1990
• High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.
  Journal of Clinical Oncology, 1989
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989
• Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival
  British Journal of Cancer, 1989
• Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.
  Journal of Clinical Oncology, 1987
• Confidence Intervals for Reporting Results of Clinical Trials
  Annals of Internal Medicine, 1986
• Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950s, 1960s, and 1970s
  Cancer, 1985
• Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
  1975